All Comments by Hiroshi Mori

  1. Estrogen replacement therapy and longitudinal decline in visual memory. A possible protective effect?
  2. Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease.
  3. Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability.
  4. Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies.
  5. Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease.
  6. Inhibiting the formation of classical C3-convertase on the Alzheimer's beta-amyloid peptide.
  7. Diffuse plaques in the striatum in Alzheimer disease (AD): relationship to the striatal mosaic and selected neuropeptide markers.
  8. Alzheimer's alpha-secretase may be a calcium-dependent protease.
  9. Melatonin alters the metabolism of the beta-amyloid precursor protein in the neuroendocrine cell line PC12.
  10. Synaptic transmission and hippocampal long-term potentiation in transgenic mice expressing FAD-linked presenilin 1.
  11. Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala-->Gly mutation.
  12. Abeta42, presenilins, and Alzheimer's disease.
  13. Apolipoprotein E promotes the binding and uptake of beta-amyloid into Chinese hamster ovary cells in an isoform-specific manner.
  14. Alpha-2 macroglobulin is genetically associated with Alzheimer disease.
  15. Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice.